Santosh Varalwar
About Santosh Varalwar
Data last updated:
Santosh Varalwar is a Managing Director at Vivimed Labs Limited (since 1989), Director at Anand Eye Institute Private Limited (since 2012) and Nominee Director at Uquifa India Private Limited (since 2017), and holds 3 more current directorships. The companies operate in FMCG, Healthcare and Pharma. The 5 current companies with reported revenue have a combined latest revenue of ₹154 Cr; the largest is Vivimed Labs Limited at ₹121 Cr (FY 2025). Earlier, Santosh Varalwar was a Director at Demas Properties & Infrastructures Private Limited (2007–2013) and Director at Yantra Green Power Private Limited (2013–2017) and 11 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vivimed Labs Limited L02411KA1988PLC009465 | Managing Director | 09 Nov 1989 | 1988 | ₹121 Cr (FY 2025) | Active |
 Anand Eye Institute Private Limited U85110TG2007PTC052208 | Director | 01 Oct 2012 | 2007 | ₹15.25 Cr (FY 2025) | Active |
 Uquifa India Private Limited U24304TG2017FTC118240 | Nominee Director | 12 Jul 2017 | 2017 | ₹11.17 Cr (FY 2023) | Active |
| Kreative Hosts Atria Private Limited U55101TG2007PTC056676 | Director | 13 Dec 2007 | 2007 | ₹6.18 Cr (FY 2019) | Active |
| B B R Projects Private Limited U24100TG2005PTC045165 | Director | 01 Sep 2007 | 2005 | ₹1.21 Cr (FY 2021) | Active |
| Atri Pharma Research (India) Private Limited U73100TG2009PTC062684 | Director | 02 Feb 2009 | 2009 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Demas Properties & Infrastructures Private Limited U45400TG2007PTC054956 | Director | 01 Aug 2007 | 2007 | Strike Off | |
| Yantra Green Power Private Limited U40108TG2013PTC087049 | Director | 17 Apr 2013 | 2013 | ₹2.6 Lakh (FY 2024) | Active |
| Finoso Pharma Private Limited U24231TG2009PTC064774 | Director | 15 Oct 2018 | 2009 | ₹17.69 Cr (FY 2025) | Active |
| Bbr (Fine Chemicals) Private Limited U24232KA2013PTC070091 | Nominee Director | 10 Jul 2013 | 2013 | Strike Off | |
 Sanvita Biotechnologies Private Limited U24232TG2010PTC068348 | Director | 10 May 2010 | 2010 | ₹6.70 Cr (FY 2024) | Active |
 Strides Alathur Private Limited U24304MH2017PTC348859 | Director | 20 Feb 2017 | 2017 | ₹131 Cr (FY 2024) | Amalgamated |
| Yantra Esolarindia Private Limited U40106GJ2010PTC149746 | Director | 11 Aug 2010 | 2010 | ₹16.05 Cr (FY 2021) | Active |
| B B R Green Fields Private Limited U24100TG2013PTC086849 | Director | 09 Apr 2013 | 2013 | ₹2.90 Cr (FY 2024) | Active |
| Vivimed Labs (Alathur) Private Limited U24219MH2006PTC165760 | Director | 31 Jul 2013 | 2006 | ₹36.32 Cr (FY 2016) | Amalgamated |
 Creative Healthcare Private Limited U24230MH2005PTC154622 | Director | 14 Feb 2007 | 2005 | Amalgamated | |
 Klar Sehen Pvt Ltd U25209KA1977PTC078763 | Director | 29 Sep 2011 | 1977 | ₹38.16 Cr (FY 2016) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Santosh Varalwar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh Varalwar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh Varalwar
Santosh Varalwar currently holds 6 directorships: Vivimed Labs Limited (Managing Director, since 09 Nov 1989, revenue ₹121 Cr (FY 2025)); Anand Eye Institute Private Limited (Director, since 01 Oct 2012, revenue ₹15.25 Cr (FY 2025)); Uquifa India Private Limited (Nominee Director, since 12 Jul 2017, revenue ₹11.17 Cr (FY 2023)); Kreative Hosts Atria Private Limited (Director, since 13 Dec 2007, revenue ₹6.18 Cr (FY 2019)); B B R Projects Private Limited (Director, since 01 Sep 2007, revenue ₹1.21 Cr (FY 2021)); and 1 more.
Santosh Varalwar was first appointed on 09 Nov 1989 as Managing Director at Vivimed Labs Limited. The most recent appointment on record is 15 Oct 2018 at Finoso Pharma Private Limited.
The 5 current companies of Santosh Varalwar that report revenue have a combined latest revenue of ₹154 Cr: Vivimed Labs Limited ₹121 Cr (FY 2025); Anand Eye Institute Private Limited ₹15.25 Cr (FY 2025); Uquifa India Private Limited ₹11.17 Cr (FY 2023); Kreative Hosts Atria Private Limited ₹6.18 Cr (FY 2019); B B R Projects Private Limited ₹1.21 Cr (FY 2021).
Santosh Varalwar held 13 earlier board appointments: Demas Properties & Infrastructures Private Limited (Director, 01 Aug 2007 to 31 Jan 2013); Yantra Green Power Private Limited (Director, 17 Apr 2013 to 25 Aug 2017); Finoso Pharma Private Limited (Director, 15 Oct 2018 to 22 Feb 2022); Bbr (Fine Chemicals) Private Limited (Nominee Director, 10 Jul 2013 to 31 Oct 2015); Sanvita Biotechnologies Private Limited (Director, 10 May 2010 to 22 Dec 2018); and 8 more.
The current boards of Santosh Varalwar's companies include Aparna Bidarkar (Vivimed Labs Limited), Manohar Rao Varalwar (Vivimed Labs Limited), Sandeep Varalwar (Vivimed Labs Limited), Siva Prasad Jarugula (Vivimed Labs Limited), Subbarathnamma Palepu (Vivimed Labs Limited), Yugandhar Kopparthi (Vivimed Labs Limited), among others.